CH379056A - Verfahren zur Herstellung einer Kunstharz-Arzneimittel-Verbindung - Google Patents

Verfahren zur Herstellung einer Kunstharz-Arzneimittel-Verbindung

Info

Publication number
CH379056A
CH379056A CH6443958A CH6443958A CH379056A CH 379056 A CH379056 A CH 379056A CH 6443958 A CH6443958 A CH 6443958A CH 6443958 A CH6443958 A CH 6443958A CH 379056 A CH379056 A CH 379056A
Authority
CH
Switzerland
Prior art keywords
production
synthetic resin
drug compound
drug
compound
Prior art date
Application number
CH6443958A
Other languages
English (en)
Inventor
Paul Rety Stephen
Herbert Linnell Wilfred
Timmington Herbert
Original Assignee
Clinical Products Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Products Limited filed Critical Clinical Products Limited
Publication of CH379056A publication Critical patent/CH379056A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH6443958A 1957-10-03 1958-09-26 Verfahren zur Herstellung einer Kunstharz-Arzneimittel-Verbindung CH379056A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31020/57A GB838952A (en) 1957-10-03 1957-10-03 Resin-drug compounds

Publications (1)

Publication Number Publication Date
CH379056A true CH379056A (de) 1964-06-30

Family

ID=10316724

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6443958A CH379056A (de) 1957-10-03 1958-09-26 Verfahren zur Herstellung einer Kunstharz-Arzneimittel-Verbindung

Country Status (3)

Country Link
US (1) US3342685A (de)
CH (1) CH379056A (de)
GB (1) GB838952A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498687A (en) * 1945-11-01 1950-02-28 Delmar H Larsen Vasoconstrictor composition
US2677670A (en) * 1952-02-21 1954-05-04 Rohm & Haas Choline carboxylate cationexchange resins
US2830933A (en) * 1955-07-14 1958-04-15 Pfizer & Co C Vitamin b12 products and preparation thereof
BE556388A (fr) * 1956-04-13 1960-02-26 Vitamins Ltd Perfectionnements apportes a la fabrication de la pyridoxine et de ses sels.

Also Published As

Publication number Publication date
US3342685A (en) 1967-09-19
GB838952A (en) 1960-06-22

Similar Documents

Publication Publication Date Title
CH467029A (de) Verfahren zur Herstellung einer Tabaksuspension
CH350802A (de) Verfahren zur Herstellung einer füllstoffhaltigen Pressmasse
CH364248A (de) Verfahren zur Herstellung neuer Aminobenzoesäure-Derivate
CH365219A (de) Verfahren zur Herstellung einer formbaren Masse
CH408041A (de) Verfahren zur Herstellung einer Polyaminopolyessigsäure
CH415632A (de) Verfahren zur Herstellung neuer 3-Pyrrolidylmethylamine
CH465851A (de) Verfahren zur Herstellung einer plastischen Kautschukmasse
CH379056A (de) Verfahren zur Herstellung einer Kunstharz-Arzneimittel-Verbindung
CH370780A (de) Verfahren zur Herstellung neuer Ferocene
AT227426B (de) Verfahren zur Herstellung einer nichtentflammbaren Holzspanplatte
CH370089A (de) Verfahren zur Herstellung von Hydantoinen
CH379494A (de) Verfahren zur Herstellung neuer Halogenpregnene
CH335857A (de) Verfahren zur Herstellung von Kunstharzen
AT253852B (de) Verfahren zur Herstellung einer stabilen Zubereitungsform des N-(5-Nitro-2-furfuryliden)-3-amino-2-oxazolidons
CH407970A (de) Verfahren zur Herstellung neuer Telomerisate
CH376226A (de) Verfahren zur Herstellung einer Kunstharz-Arzneimittelverbindung
CH418649A (de) Verfahren zur Herstellung von Kunstharzen
AT207848B (de) Verfahren zur Herstellung einer neuen Bis-triazinylamino-Stilbenverbindung
CH366532A (de) Verfahren zur Herstellung neuer Aminosteroidverbindungen
CH371896A (de) Verfahren zur Herstellung kunststoffhaltiger Massen
CH362072A (de) Verfahren zur Herstellung neuer Acylpiperidine
CH371103A (de) Verfahren zur Herstellung einer organischen Phosphorverbindung
CH413384A (de) Verfahren zur Herstellung gehärteter Kunstharze
CH383396A (de) Verfahren zur Herstellung einer bisher unbekannten reserpinähnlichen Verbindung
CH366283A (de) Verfahren zur Herstellung neuer Dioxotetrahydropyridazine